e-learning
resources
London 2016
Sunday, 04.09.2016
Paediatric respiratory infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytokine and chemokine profile in a cohort of children with community acquired pneumonia
Joseph L Mathew (Chandigarh, India), Joseph L. Mathew, Sofia Ygberg, Sunit Singhi, Vikas Gautam, Shanie Saghafian–Hedengren, Anna Nilsson
Source:
International Congress 2016 – Paediatric respiratory infection
Session:
Paediatric respiratory infection
Session type:
Poster Discussion
Number:
1608
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Joseph L Mathew (Chandigarh, India), Joseph L. Mathew, Sofia Ygberg, Sunit Singhi, Vikas Gautam, Shanie Saghafian–Hedengren, Anna Nilsson. Cytokine and chemokine profile in a cohort of children with community acquired pneumonia. Eur Respir J 2016; 48: Suppl. 60, 1608
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
The results of immunotherapy of community acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
YKL-40 and CCL18 predict mortality in patients hospitalised with community-acquired pneumonia; an observational analysis
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Risk factors for pleural complications in children with community acquired pneumonia
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Age-depended levels of IL-2, IL-4 in children with community acquired pneumonia and wheezing
Source: International Congress 2015 – Respiratory infections in children
Year: 2015
Ultrasound characteristics of community acquired pneumonia in children
Source: International Congress 2016 – A view into a chest and pleural pathology
Year: 2016
Community acquired pneumonia in asthma patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Community acquired lung respiratory infections in HIV-infected patients: Microbial etiology and outcome
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Severe pneumonia mortality in pediatric patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016
Clinical peculiarities of mycoplasma infection in children with community pneumonia
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Serum YKL-40 is elevated in children with pneumonia and RSV infection
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014
Community acquired pneumonia, hepcidin and anemia
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Severity scores and management of community acquired pneumonia
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Exploring the immune status of sepsis patients through Tim-3 expressed on monocytes and IL-12
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
Severity and outcome of community acquired pneumonia in asthmatic patients
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Follow-up of infants hospitalized for bronchiolitis. Clinical factors that determine their evolution
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015
Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Asthma diagnosis in children with community-acquired pneumonia: New challenges
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept